These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 39102216)

  • 1. Targeting WNT5B and WNT10B in osteosarcoma.
    Miranda-Carboni GA; Krum SA
    Oncotarget; 2024 Aug; 15():535-540. PubMed ID: 39102216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wnt signaling in osteosarcoma.
    Lin CH; Ji T; Chen CF; Hoang BH
    Adv Exp Med Biol; 2014; 804():33-45. PubMed ID: 24924167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The canonical Wnt-beta-catenin pathway in development and chemotherapy of osteosarcoma.
    Li C; Shi X; Zhou G; Liu X; Wu S; Zhao J
    Front Biosci (Landmark Ed); 2013 Jun; 18(4):1384-91. PubMed ID: 23747891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functionalized curcumin analogs as potent modulators of the Wnt/β-catenin signaling pathway.
    Leow PC; Bahety P; Boon CP; Lee CY; Tan KL; Yang T; Ee PL
    Eur J Med Chem; 2014 Jan; 71():67-80. PubMed ID: 24275249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of oleandrin on the proliferation show and invasion of osteosarcoma cells in vitro by suppressing Wnt/β-catenin signaling pathway.
    Ma Y; Zhu B; Liu X; Yu H; Yong L; Liu X; Shao J; Liu Z
    J Exp Clin Cancer Res; 2015 Oct; 34():115. PubMed ID: 26444270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FHL2 silencing reduces Wnt signaling and osteosarcoma tumorigenesis in vitro and in vivo.
    Brun J; Dieudonné FX; Marty C; Müller J; Schüle R; Patiño-García A; Lecanda F; Fromigué O; Marie PJ
    PLoS One; 2013; 8(1):e55034. PubMed ID: 23383046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyphyllin I suppresses human osteosarcoma growth by inactivation of Wnt/β-catenin pathway in vitro and in vivo.
    Chang J; Li Y; Wang X; Hu S; Wang H; Shi Q; Wang Y; Yang Y
    Sci Rep; 2017 Aug; 7(1):7605. PubMed ID: 28790389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of adriamycin resistance in osteosarcoma by blocking Wnt/β-catenin signal pathway.
    Wu BQ; Cao Y; Bi ZG
    Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3185-3192. PubMed ID: 28770967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Wnt signaling pathway: implications for therapy in osteosarcoma.
    McQueen P; Ghaffar S; Guo Y; Rubin EM; Zi X; Hoang BH
    Expert Rev Anticancer Ther; 2011 Aug; 11(8):1223-32. PubMed ID: 21916576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt10b activates the Wnt, notch, and NFκB pathways in U2OS osteosarcoma cells.
    Mödder UI; Oursler MJ; Khosla S; Monroe DG
    J Cell Biochem; 2011 May; 112(5):1392-402. PubMed ID: 21321991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone methyltransferase SETD2 regulates osteosarcoma cell growth and chemosensitivity by suppressing Wnt/β-catenin signaling.
    Jiang C; He C; Wu Z; Li F; Xiao J
    Biochem Biophys Res Commun; 2018 Jul; 502(3):382-388. PubMed ID: 29842882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Insights about the Wnt/β-Catenin Signaling Pathway in Primary Bone Tumors and Their Microenvironment: A Promising Target to Develop Therapeutic Strategies?
    Danieau G; Morice S; Rédini F; Verrecchia F; Royer BB
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31370265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and the clinical significance of Wnt10a and Wnt10b in endometrial cancer are associated with the Wnt/β-catenin pathway.
    Chen H; Wang Y; Xue F
    Oncol Rep; 2013 Feb; 29(2):507-14. PubMed ID: 23135473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dihydroartemisinin inhibits tumor growth of human osteosarcoma cells by suppressing Wnt/β-catenin signaling.
    Liu Y; Wang W; Xu J; Li L; Dong Q; Shi Q; Zuo G; Zhou L; Weng Y; Tang M; He T; Luo J
    Oncol Rep; 2013 Oct; 30(4):1723-30. PubMed ID: 23917613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WNT5B drives osteosarcoma stemness, chemoresistance and metastasis.
    Perkins RS; Murray G; Suthon S; Davis L; Perkins NB; Fletcher L; Bozzi A; Schreiber SL; Lin J; Laxton S; Pillai RR; Wright AJ; Miranda-Carboni GA; Krum SA
    Clin Transl Med; 2024 May; 14(5):e1670. PubMed ID: 38689429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Wnt10b on dermal papilla cells via the canonical Wnt/β-catenin signalling pathway in the Angora rabbit.
    Bai L; Gao S; Sun H; Zhao X; Yang L; Hu H; Sun J; Jiang W
    J Anim Physiol Anim Nutr (Berl); 2019 Sep; 103(5):1602-1609. PubMed ID: 31241227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing microRNA-27a inhibits proliferation and invasion of human osteosarcoma cells through the SFRP1-dependent Wnt/β-catenin signaling pathway.
    Mu Y; Zhang L; Chen X; Chen S; Shi Y; Li J
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31072914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt pathway in osteosarcoma, from oncogenic to therapeutic.
    Cai Y; Cai T; Chen Y
    J Cell Biochem; 2014 Apr; 115(4):625-31. PubMed ID: 24190862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-Elemonic acid inhibits the growth of human Osteosarcoma through endoplasmic reticulum (ER) stress-mediated PERK/eIF2α/ATF4/CHOP activation and Wnt/β-catenin signal suppression.
    Zhao A; Zhang Z; Zhou Y; Li X; Li X; Ma B; Zhang Q
    Phytomedicine; 2020 Apr; 69():153183. PubMed ID: 32113150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-148a suppresses epithelial-mesenchymal transition and invasion of pancreatic cancer cells by targeting Wnt10b and inhibiting the Wnt/β-catenin signaling pathway.
    Peng L; Liu Z; Xiao J; Tu Y; Wan Z; Xiong H; Li Y; Xiao W
    Oncol Rep; 2017 Jul; 38(1):301-308. PubMed ID: 28586066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.